Baxter International is a US company operating worldwide in the pharmaceutical and medical technology sectors. The company produces drugs for anesthesiology and intensive care medicine, vaccines and medical devices.
As of April 2025 Baxter has a market cap of ยฃ11.65 Billion. This makes Baxter the world's 1183th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Marketcap | Change |
---|---|---|
2025 | ยฃ11.65 B | -1.89% |
2024 | ยฃ11.88 B | -22.83% |
2023 | ยฃ15.39 B | -27.52% |
2022 | ยฃ21.23 B | -33.3% |
2021 | ยฃ31.84 B | 5.89% |
2020 | ยฃ30.07 B | -6.84% |
2019 | ยฃ32.27 B | 21.34% |
2018 | ยฃ26.60 B | 2.08% |
2017 | ยฃ26.05 B | 33.32% |
2016 | ยฃ19.54 B | 38.63% |
2015 | ยฃ14.09 B | -44.78% |
2014 | ยฃ25.53 B | 11.51% |
2013 | ยฃ22.89 B | 1.64% |
2012 | ยฃ22.52 B | 25.5% |
2011 | ยฃ17.95 B | -5.74% |
2010 | ยฃ19.04 B | -12.62% |
2009 | ยฃ21.79 B | -3.9% |
2008 | ยฃ22.67 B | 22.32% |
2007 | ยฃ18.53 B | 20.33% |
2006 | ยฃ15.40 B | 12.92% |
2005 | ยฃ13.64 B | 22.72% |
2004 | ยฃ11.11 B | 6.07% |
2003 | ยฃ10.48 B | 0.11% |
2002 | ยฃ10.46 B | -52.74% |
2001 | ยฃ22.15 B | 27.69% |
2000 | ยฃ17.34 B | 53.77% |
1999 | ยฃ11.28 B | 1.87% |
1998 | ยฃ11.07 B | 28.8% |
1997 | ยฃ8.59 B | 31.81% |
1996 | ยฃ6.52 B |
On Apr 23rd, 2025 the market cap of Baxter was reported to be: